Background: Chronic Renal Failure (CRF) is characterized by gradual, progressive and permanent decrease in the renal functions. Moreover, CRF adversely effects the functioning of the various other organs. Dyslipidemia is the characteristic of the CRF, moreover lipid profile disorder appear from the onset of the CRF. However, severity of disturbance depends on the stage of CRF. MDA one of the important marker of oxidative stress is the product of lipid peroxidation, which is produced by oxidation of poly unsaturated fatty acid. Increased oxidative stress leads to distruction of bio-molecules, protein, DNA and RNA of the cells. Methods: This was a cross sectional type of study conducted in the TMMC & RC, Moradabad (U.P.). Total sixty patients of CRF patients > 20 years were included in the study. Lipid profile which included serum concentration of total cholesterol (TC), triglycerides (TG) and high density lipoprotein (HDL) were calculated enzymatic method CHOD-POD method, GPO-PAP method, CHOD-POD/ Phosphotungstate method respectively Results: There was a significant difference between the mean values of TC (< 0.001), TG (< 0.001), LDL (< 0.001), VLDL (< 0.001) of CRF patients and Control group III. MDA level was significantly high in group I and group II compare to group III. Further, the levels of MDA were significantly high in group I CRF patients on dialysis when compared to group II conservatively managed patients (p < 0.001). Conclusion: Findings of the present study showed that there is increased oxidative stress level as well elevated risk of CVD in CRF patients on dialysis. More of altered level of lipids induces atherosclerosis in CRF patients. Therefore, the present study suggest that management lipids and oxidative stress should be included during the treatment of CRF patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.